The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

Children and teens with type 2 diabetes are more likely to receive insulin than newer GLP-1 receptor agonists, according to a new study published in Pediatrics. Current guidelines from the American ...

Nation’s largest urgent care network to pilot medically supervised weight management services including potential use of GLP-1s. BIRMINGHAM, Ala., March 10, 2026--(BUSINESS WIRE ...

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

In veterans with type 2 diabetes, treatment with GLP-1 receptor agonists was associated with a reduced risk for various substance use disorders compared with sodium-glucose cotransporter-2, or SGLT-2, ...

The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies for effective long-term weight loss.

Dual therapy with a GLP-1 receptor agonist plus ixekizumab demonstrates long-term benefits in psoriatic disease activity, ...

New data showed childhood obesity has hit a record high in recent years, while federal changes such as cuts to food assistance programs and a revamped food pyramid ...

Here are five key takeaways for regarding the use of GLP-1 receptor agonists in patients who are undergoing breast cancer ...

Vogue spoke to leading experts to find out what’s next on our plates. With around 12% of the United States now believed to be ...

Read more about how GLP-1RAs can help people quit smoking through dampening nicotine-seeking behaviours and activity in the brain’s reward pathway.